These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

325 related items for PubMed ID: 25124771

  • 1. Are 20 human papillomavirus types causing cervical cancer?
    Arbyn M, Tommasino M, Depuydt C, Dillner J.
    J Pathol; 2014 Dec; 234(4):431-5. PubMed ID: 25124771
    [Abstract] [Full Text] [Related]

  • 2. The clinical utility of extended high-risk HPV genotyping in risk-stratifying women with L-SIL cytology: A retrospective study of 8726 cases.
    Tao X, Zhang H, Zhang H, Xiao Y, Zhong F, Zhou X, Cong Q, Sui L, Zhao C.
    Cancer Cytopathol; 2022 Jul; 130(7):542-550. PubMed ID: 35312217
    [Abstract] [Full Text] [Related]

  • 3. Age at last screening and remaining lifetime risk of cervical cancer in older, unvaccinated, HPV-negative women: a modelling study.
    Malagón T, Kulasingam S, Mayrand MH, Ogilvie G, Smith L, Bouchard C, Gotlieb W, Franco EL.
    Lancet Oncol; 2018 Dec; 19(12):1569-1578. PubMed ID: 30392810
    [Abstract] [Full Text] [Related]

  • 4. Nationwide comprehensive human papillomavirus (HPV) genotyping of invasive cervical cancer.
    Lagheden C, Eklund C, Lamin H, Kleppe SN, Lei J, Elfström KM, Sundström K, Andrae B, Sparén P, Dillner J.
    Br J Cancer; 2018 May; 118(10):1377-1381. PubMed ID: 29559733
    [Abstract] [Full Text] [Related]

  • 5. Pathogenic role of the eight probably/possibly carcinogenic HPV types 26, 53, 66, 67, 68, 70, 73 and 82 in cervical cancer.
    Halec G, Alemany L, Lloveras B, Schmitt M, Alejo M, Bosch FX, Tous S, Klaustermeier JE, Guimerà N, Grabe N, Lahrmann B, Gissmann L, Quint W, Bosch FX, de Sanjose S, Pawlita M, Retrospective International Survey and HPV Time Trends Study Group, Retrospective International Survey and HPV Time Trends Study Group.
    J Pathol; 2014 Dec; 234(4):441-51. PubMed ID: 25043390
    [Abstract] [Full Text] [Related]

  • 6. Phylogenetic considerations in designing a broadly protective multimeric L2 vaccine.
    Jagu S, Kwak K, Schiller JT, Lowy DR, Kleanthous H, Kalnin K, Wang C, Wang HK, Chow LT, Huh WK, Jaganathan KS, Chivukula SV, Roden RB.
    J Virol; 2013 Jun; 87(11):6127-36. PubMed ID: 23536682
    [Abstract] [Full Text] [Related]

  • 7. Comparison of real-time multiplex human papillomavirus (HPV) PCR assays with INNO-LiPA HPV genotyping extra assay.
    Else EA, Swoyer R, Zhang Y, Taddeo FJ, Bryan JT, Lawson J, Van Hyfte I, Roberts CC.
    J Clin Microbiol; 2011 May; 49(5):1907-12. PubMed ID: 21068278
    [Abstract] [Full Text] [Related]

  • 8. Detection of rare and possibly carcinogenic human papillomavirus genotypes as single infections in invasive cervical cancer.
    Geraets D, Alemany L, Guimera N, de Sanjose S, de Koning M, Molijn A, Jenkins D, Bosch X, Quint W, RIS HPV TT Study Group.
    J Pathol; 2012 Dec; 228(4):534-43. PubMed ID: 22711526
    [Abstract] [Full Text] [Related]

  • 9. Human papillomavirus genotype distribution in invasive cervical cancer in Bosnia and Herzegovina.
    Iljazović E, Mena M, Tous S, Alemany L, Omeragić F, Sadiković A, Clavero O, Vergara M, Bosch FX, de Sanjosé S.
    Cancer Epidemiol; 2014 Oct; 38(5):504-10. PubMed ID: 25130915
    [Abstract] [Full Text] [Related]

  • 10. Prevalent characteristics of human papillomavirus infection in 29,508 women in Jinshan District, Shanghai.
    Yu Y, Liu HL, He CF, Wang Y, Fu WJ, Gan GP, Qu HL, Zhou YN, Yao L.
    Taiwan J Obstet Gynecol; 2022 Nov; 61(6):971-976. PubMed ID: 36428000
    [Abstract] [Full Text] [Related]

  • 11. Vaccine-related HPV genotypes in women with and without cervical cancer in Mozambique: burden and potential for prevention.
    Castellsagué X, Klaustermeier J, Carrilho C, Albero G, Sacarlal J, Quint W, Kleter B, Lloveras B, Ismail MR, de Sanjosé S, Bosch FX, Alonso P, Menéndez C.
    Int J Cancer; 2008 Apr 15; 122(8):1901-4. PubMed ID: 18076064
    [Abstract] [Full Text] [Related]

  • 12. Type-dependent E6/E7 mRNA expression of single and multiple high-risk human papillomavirus infections in cervical neoplasia.
    Andersson E, Kärrberg C, Rådberg T, Blomqvist L, Zetterqvist BM, Ryd W, Lindh M, Horal P.
    J Clin Virol; 2012 May 15; 54(1):61-5. PubMed ID: 22326759
    [Abstract] [Full Text] [Related]

  • 13. HPV genotype distribution among women with normal and abnormal cervical cytology presenting in a tertiary gynecology referral Clinic in Ethiopia.
    Wolday D, Derese M, Gebressellassie S, Tsegaye B, Ergete W, Gebrehiwot Y, Caplan O, Wolf DG, Maayan S.
    Infect Agent Cancer; 2018 May 15; 13():28. PubMed ID: 30127841
    [Abstract] [Full Text] [Related]

  • 14. Prevalence of genotype-specific human papillomavirus infection and cervical neoplasia in Taiwan: a community-based survey of 10,602 women.
    Chen HC, You SL, Hsieh CY, Schiffman M, Lin CY, Pan MH, Chou YC, Liaw KL, Hsing AW, Chen CJ, CBCSP-HPV Study Group.
    Int J Cancer; 2011 Mar 01; 128(5):1192-203. PubMed ID: 20853317
    [Abstract] [Full Text] [Related]

  • 15. Human papillomavirus (HPV) subtypes and their relationships with cervical smear results in cervical cancer screening: a community-based study from the central Anatolia region of Turkey.
    Findik S, Findik S, Abuoğlu S, Cihan FG, Ilter H, Iyisoy MS.
    Int J Clin Exp Pathol; 2019 Mar 01; 12(4):1391-1398. PubMed ID: 31933954
    [Abstract] [Full Text] [Related]

  • 16. Prevaccination distribution of human papillomavirus types in women attending at cervical cancer screening in Belgium.
    Arbyn M, Benoy I, Simoens C, Bogers J, Beutels P, Depuydt C.
    Cancer Epidemiol Biomarkers Prev; 2009 Jan 01; 18(1):321-30. PubMed ID: 19124515
    [Abstract] [Full Text] [Related]

  • 17. Determination of human papillomavirus type in archival tissue specimens of invasive cervical cancer using molecular mapping and E6/E7-based polymerase chain reaction.
    Sakamoto J, Saito M, Zhang S, Takakura M, Takagi H, Sasagawa T.
    PLoS One; 2022 Jan 01; 17(4):e0265996. PubMed ID: 35381047
    [Abstract] [Full Text] [Related]

  • 18. Genetic diversity of human papillomavirus types 35, 45 and 58 in cervical cancer in Brazil.
    Basto DL, Vidal JP, Pontes VB, Felix SP, Pinto LC, Soares BM, Martins LF, Correa FM, Montenegro RC, Chaves CBP, Almeida LM, Moreira MÂM.
    Arch Virol; 2017 Sep 01; 162(9):2855-2860. PubMed ID: 28597068
    [Abstract] [Full Text] [Related]

  • 19. Prevention of human papillomavirus-associated cancers.
    Dillner J.
    Semin Oncol; 2015 Apr 01; 42(2):272-83. PubMed ID: 25843731
    [Abstract] [Full Text] [Related]

  • 20. Rates and determinants of incidence and clearance of cervical HPV genotypes among HIV-seropositive women in Pune, India.
    Mane A, Sahasrabuddhe VV, Nirmalkar A, Risbud AR, Sahay S, Bhosale RA, Vermund SH, Mehendale SM.
    J Clin Virol; 2017 Mar 01; 88():26-32. PubMed ID: 28152432
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.